Conformationally defined adrenergic agents. II. The effect of endo- and exo-2-aminobenzobicyclo-[2.2.2] octene, conformationally defined amphetamine analogs, on the uptake and release of central catecholamines.
D000661:Amphetamine / Q000494:pharmacology; D000662:Amphetamines / Q000378:metabolism / Q000494:pharmacology*; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure; D002395:Catecholamines / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism; D066298:In Vitro Techniques; D008297:Male; D008694:Methamphetamine / Q000494:pharmacology; D008968:Molecular Conformation; D009043:Motor Activity / Q000187:drug effects; D009638:Norepinephrine / Q000378:metabolism; D051381:Rats; D012995:Solubility; D013329:Structure-Activity Relationship; D013574:Synaptosomes / Q000378:metabolism
D000662:Amphetamines; D002395:Catecholamines; D008694:Methamphetamine; D000661:Amphetamine; D004298:Dopamine; D009638:Norepinephrine